NCT03106220 is a NA clinical trial of exercise in Sarcopenia, sponsored by Mayo Clinic.

Who is sponsoring NCT03106220?

NCT03106220 is sponsored by Mayo Clinic.

What drugs are being tested in NCT03106220?

Interventions in NCT03106220: exercise, placebo.

What condition does NCT03106220 study?

NCT03106220 studies Sarcopenia, Debility Due to Disease.

Is NCT03106220 still recruiting?

NCT03106220 is currently terminated. Last updated 5 March 2021.

Last reviewed 2021-03-05 · How we verify

NCT03106220

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exercise Intervention - and Impact on Hospitalization

Terminated NA Last updated 5 March 2021

What this trial tests

NA trial testing exercise in Sarcopenia in 19 participants. Terminated before completion.

Timeline

1 March 2017

Primary endpoint
14 January 2021

14 January 2021

Quick facts

Lead sponsor	Mayo Clinic
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	prevention
Enrollment	19
Start date	1 March 2017
Primary completion	14 January 2021
Estimated completion	14 January 2021
Sites	3 locations across United States

Drugs / interventions tested

exercise
placebo

Conditions studied

Sarcopenia — all drugs for Sarcopenia →
Debility Due to Disease — all drugs for Debility Due to Disease →

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Sarcopenia or Debility Due to Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Skeletal muscle abnormalities (sarcopenia) and frailty are common complications seen in patients with end-stage liver disease. The presence of these complications portends poor prognosis. The purpose of this study is to assess the impact of a formal home based video strengthening program (REST) on sarcopenia and frailty. We also want to assess the impact of this exercise program on complication rates, hospitalization, on quality of life (QOL) and on survival.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of exercise

Trials testing the same drug.

NCT07447193 — Investigation of Pain Perception According to Gender in Individuals With Scoliosis · NA · recruiting
NCT07448467 — Investigation of the Effectiveness of Progressive Resistance Exercise Training in the Management of Lymphedema. · NA · recruiting
NCT07442396 — The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation · NA · recruiting
NCT07442409 — The Effect of Ergonomics and Exercise Training on Musculoskeletal Disorders in Female Dairy Farmers · NA · recruiting
NCT07379801 — The Musculoskeletal System During Puberty in Dancers With Scoliosis, and the Effect of an Exercise Program · NA · recruiting

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting

Other Mayo Clinic trials

Trials by the same sponsor.

NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03106220 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 5 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03106220.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing